nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.687	1	CbGbCtD
Anagrelide—Alveolitis allergic—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0483	CcSEcCtD
Anagrelide—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.00912	0.0292	CcSEcCtD
Anagrelide—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00695	0.0222	CcSEcCtD
Anagrelide—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00602	0.0192	CcSEcCtD
Anagrelide—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00557	0.0178	CcSEcCtD
Anagrelide—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00515	0.0165	CcSEcCtD
Anagrelide—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00511	0.0163	CcSEcCtD
Anagrelide—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00507	0.0162	CcSEcCtD
Anagrelide—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00446	0.0143	CcSEcCtD
Anagrelide—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00434	0.0139	CcSEcCtD
Anagrelide—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00425	0.0136	CcSEcCtD
Anagrelide—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00417	0.0133	CcSEcCtD
Anagrelide—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00402	0.0128	CcSEcCtD
Anagrelide—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00399	0.0128	CcSEcCtD
Anagrelide—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00394	0.0126	CcSEcCtD
Anagrelide—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00385	0.0123	CcSEcCtD
Anagrelide—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00381	0.0122	CcSEcCtD
Anagrelide—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00374	0.012	CcSEcCtD
Anagrelide—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00362	0.0116	CcSEcCtD
Anagrelide—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00357	0.0114	CcSEcCtD
Anagrelide—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00336	0.0107	CcSEcCtD
Anagrelide—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00326	0.0104	CcSEcCtD
Anagrelide—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00316	0.0101	CcSEcCtD
Anagrelide—Injury—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00996	CcSEcCtD
Anagrelide—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00974	CcSEcCtD
Anagrelide—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00966	CcSEcCtD
Anagrelide—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00942	CcSEcCtD
Anagrelide—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00938	CcSEcCtD
Anagrelide—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00915	CcSEcCtD
Anagrelide—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00915	CcSEcCtD
Anagrelide—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00915	CcSEcCtD
Anagrelide—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00901	CcSEcCtD
Anagrelide—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00851	CcSEcCtD
Anagrelide—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00845	CcSEcCtD
Anagrelide—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00836	CcSEcCtD
Anagrelide—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00253	0.0081	CcSEcCtD
Anagrelide—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00791	CcSEcCtD
Anagrelide—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00791	CcSEcCtD
Anagrelide—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00791	CcSEcCtD
Anagrelide—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00776	CcSEcCtD
Anagrelide—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00771	CcSEcCtD
Anagrelide—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00761	CcSEcCtD
Anagrelide—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00237	0.00759	CcSEcCtD
Anagrelide—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00751	CcSEcCtD
Anagrelide—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0074	CcSEcCtD
Anagrelide—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00731	CcSEcCtD
Anagrelide—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00729	CcSEcCtD
Anagrelide—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00722	CcSEcCtD
Anagrelide—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00225	0.0072	CcSEcCtD
Anagrelide—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00716	CcSEcCtD
Anagrelide—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00222	0.0071	CcSEcCtD
Anagrelide—Depression—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00703	CcSEcCtD
Anagrelide—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00695	CcSEcCtD
Anagrelide—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00692	CcSEcCtD
Anagrelide—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00686	CcSEcCtD
Anagrelide—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00676	CcSEcCtD
Anagrelide—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00673	CcSEcCtD
Anagrelide—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00209	0.00667	CcSEcCtD
Anagrelide—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00665	CcSEcCtD
Anagrelide—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00662	CcSEcCtD
Anagrelide—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00637	CcSEcCtD
Anagrelide—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00635	CcSEcCtD
Anagrelide—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00633	CcSEcCtD
Anagrelide—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00633	CcSEcCtD
Anagrelide—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00197	0.0063	CcSEcCtD
Anagrelide—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00629	CcSEcCtD
Anagrelide—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00625	CcSEcCtD
Anagrelide—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00624	CcSEcCtD
Anagrelide—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00622	CcSEcCtD
Anagrelide—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00621	CcSEcCtD
Anagrelide—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00592	CcSEcCtD
Anagrelide—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00588	CcSEcCtD
Anagrelide—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00571	CcSEcCtD
Anagrelide—Chills—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00568	CcSEcCtD
Anagrelide—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00566	CcSEcCtD
Anagrelide—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00175	0.0056	CcSEcCtD
Anagrelide—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00551	CcSEcCtD
Anagrelide—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00543	CcSEcCtD
Anagrelide—Tension—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00541	CcSEcCtD
Anagrelide—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00535	CcSEcCtD
Anagrelide—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00533	CcSEcCtD
Anagrelide—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0053	CcSEcCtD
Anagrelide—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00512	CcSEcCtD
Anagrelide—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0051	CcSEcCtD
Anagrelide—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00497	CcSEcCtD
Anagrelide—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00494	CcSEcCtD
Anagrelide—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00487	CcSEcCtD
Anagrelide—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00485	CcSEcCtD
Anagrelide—Cough—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00481	CcSEcCtD
Anagrelide—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00478	CcSEcCtD
Anagrelide—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00476	CcSEcCtD
Anagrelide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00469	CcSEcCtD
Anagrelide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00469	CcSEcCtD
Anagrelide—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00469	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00466	CcSEcCtD
Anagrelide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00464	CcSEcCtD
Anagrelide—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00459	CcSEcCtD
Anagrelide—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00454	CcSEcCtD
Anagrelide—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0045	CcSEcCtD
Anagrelide—Infection—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00447	CcSEcCtD
Anagrelide—Shock—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00443	CcSEcCtD
Anagrelide—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00441	CcSEcCtD
Anagrelide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00441	CcSEcCtD
Anagrelide—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00439	CcSEcCtD
Anagrelide—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00437	CcSEcCtD
Anagrelide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00435	CcSEcCtD
Anagrelide—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00429	CcSEcCtD
Anagrelide—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0042	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0041	CcSEcCtD
Anagrelide—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00407	CcSEcCtD
Anagrelide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00404	CcSEcCtD
Anagrelide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00401	CcSEcCtD
Anagrelide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00125	0.004	CcSEcCtD
Anagrelide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00396	CcSEcCtD
Anagrelide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00391	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00388	CcSEcCtD
Anagrelide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00388	CcSEcCtD
Anagrelide—Pain—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00385	CcSEcCtD
Anagrelide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00385	CcSEcCtD
Anagrelide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00371	CcSEcCtD
Anagrelide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00368	CcSEcCtD
Anagrelide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00357	CcSEcCtD
Anagrelide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00356	CcSEcCtD
Anagrelide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00356	CcSEcCtD
Anagrelide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00323	CcSEcCtD
Anagrelide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000996	0.00318	CcSEcCtD
Anagrelide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000963	0.00308	CcSEcCtD
Anagrelide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000931	0.00298	CcSEcCtD
Anagrelide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000895	0.00286	CcSEcCtD
Anagrelide—Rash—Riluzole—amyotrophic lateral sclerosis	0.000887	0.00284	CcSEcCtD
Anagrelide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000886	0.00283	CcSEcCtD
Anagrelide—Headache—Riluzole—amyotrophic lateral sclerosis	0.000882	0.00282	CcSEcCtD
Anagrelide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000836	0.00267	CcSEcCtD
